Remove tag equitable-access
article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

Additionally, in August 2022, the latest federal data-sharing memorandum, Ensuring Free, Immediate, and Equitable Access to Federally Funded Research Memorandum (2022 OSTP Memo), was released requiring articles resulting from federal funding be made “freely available and publicly accessible” without embargo or delay.

article thumbnail

Grand Rounds August 12, 2022: Equitably Including Diverse Participants in Pragmatic Clinical Trials (Consuelo H. Wilkins, MD, MSCI)

Rethinking Clinical Trials

Because the system and structures have not been built equitability, we will need to invest more and have more transparency and accountability at every level, from the investigator, funder, publisher and journals. The recruitment plan needs to include study materials that are tailored and accessible to the research population.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Rethinking Clinical Trials

SNAP Online Purchasing Pilot rapidly expanded during the pandemic with the goal of creating equitable access to online grocery shopping, leading to the growth of online grocery shopping sales among those with low incomes.

article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

Tags #pctGR, @Collaboratory1 The post Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. Many patients did not answer the phone. There were also patients who wanted to talk to their doctor, and they needed time to pull in their provider.

article thumbnail

WHO update on Omicron

The Pharma Data

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries.

article thumbnail

No sign of stopping: The rise of cell and gene therapy

Drug Discovery World

But are these price tags a barrier to access? Biotech and pharma are actively working with payers and insurers to deliver on equitable pricing models that ensure access. It is imperative that these payment processes are supported to expand access. million per dose.

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.